Developer - OpenAI, Inc.
GPT‑Rosalind, scientific research and drug discovery, OpenAI, Inc., San Francisco, California, USA
- Thread starter Administrator
- Start date
"Introducing GPT‑Rosalind for life sciences research"
A new purpose-built model to accelerate scientific research and drug discovery.
April 16, 2026
A new purpose-built model to accelerate scientific research and drug discovery.
April 16, 2026
Similar threads
